BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22403616)

  • 1. XIAP is a predictor of cisplatin-based chemotherapy response and prognosis for patients with advanced head and neck cancer.
    Yang XH; Feng ZE; Yan M; Hanada S; Zuo H; Yang CZ; Han ZG; Guo W; Chen WT; Zhang P
    PLoS One; 2012; 7(3):e31601. PubMed ID: 22403616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wee-1 Kinase Inhibition Sensitizes High-Risk HPV+ HNSCC to Apoptosis Accompanied by Downregulation of MCl-1 and XIAP Antiapoptotic Proteins.
    Tanaka N; Patel AA; Wang J; Frederick MJ; Kalu NN; Zhao M; Fitzgerald AL; Xie TX; Silver NL; Caulin C; Zhou G; Skinner HD; Johnson FM; Myers JN; Osman AA
    Clin Cancer Res; 2015 Nov; 21(21):4831-44. PubMed ID: 26124202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of DNA translesion synthesis polymerase η in head and neck squamous cell cancer predicts resistance to gemcitabine and cisplatin-based chemotherapy.
    Zhou W; Chen YW; Liu X; Chu P; Loria S; Wang Y; Yen Y; Chou KM
    PLoS One; 2013; 8(12):e83978. PubMed ID: 24376779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting X chromosome-linked inhibitor of apoptosis protein in mucoepidermoid carcinoma of the head and neck: A novel therapeutic strategy using nitidine chloride.
    Kwon HJ; Yoon K; Jung JY; Ryu MH; Kim SH; Yoo ES; Choi SY; Yang IH; Hong SD; Shin JA; Cho SD
    J Mol Med (Berl); 2020 Nov; 98(11):1591-1602. PubMed ID: 32901343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Over-expression of BAG-1 in head and neck squamous cell carcinomas (HNSCC) is associated with cisplatin-resistance.
    Liu S; Ren B; Gao H; Liao S; Zhai YX; Li S; Su XJ; Jin P; Stroncek D; Xu Z; Zeng Q; Li Y
    J Transl Med; 2017 Sep; 15(1):189. PubMed ID: 28877725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel role for BDNF-TrkB in the regulation of chemotherapy resistance in head and neck squamous cell carcinoma.
    Lee J; Jiffar T; Kupferman ME
    PLoS One; 2012; 7(1):e30246. PubMed ID: 22276165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gelsolin regulates cisplatin sensitivity in human head-and-neck cancer.
    Wang PW; Abedini MR; Yang LX; Ding AA; Figeys D; Chang JY; Tsang BK; Shieh DB
    Int J Cancer; 2014 Dec; 135(12):2760-9. PubMed ID: 24771612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SERPINB2 down-regulation contributes to chemoresistance in head and neck cancer.
    Huang Z; Li H; Huang Q; Chen D; Han J; Wang L; Pan C; Chen W; House MG; Nephew KP; Guo Z
    Mol Carcinog; 2014 Oct; 53(10):777-86. PubMed ID: 23661500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic and chemotherapeutic implications of a novel four-gene pyroptosis model in head and neck squamous cell carcinoma.
    Yuan P; Jiang S; Wang Q; Wu Y; Jiang Y; Xu H; Jiang L; Luo X
    PeerJ; 2024; 12():e17296. PubMed ID: 38756442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-expression of XIAP and CIAP1 Play Synergistic Effect on Patient's Prognosis in Head and Neck Cancer.
    Yang XH; Liu L; Hu YJ; Zhang P; Hu QG
    Pathol Oncol Res; 2019 Jul; 25(3):1111-1116. PubMed ID: 30421089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chk1/2 inhibition overcomes the cisplatin resistance of head and neck cancer cells secondary to the loss of functional p53.
    Gadhikar MA; Sciuto MR; Alves MV; Pickering CR; Osman AA; Neskey DM; Zhao M; Fitzgerald AL; Myers JN; Frederick MJ
    Mol Cancer Ther; 2013 Sep; 12(9):1860-73. PubMed ID: 23839309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KiSS1 mediates platinum sensitivity and metastasis suppression in head and neck squamous cell carcinoma.
    Jiffar T; Yilmaz T; Lee J; Hanna E; El-Naggar A; Yu D; Myers JN; Kupferman ME
    Oncogene; 2011 Jul; 30(28):3163-73. PubMed ID: 21383688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NM23-H1 expression of head and neck squamous cell carcinoma in association with the response to cisplatin treatment.
    Wang YF; Chang CJ; Chiu JH; Lin CP; Li WY; Chang SY; Chu PY; Tai SK; Chen YJ
    Oncotarget; 2014 Sep; 5(17):7392-405. PubMed ID: 25277180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Livin enhances chemoresistance in head and neck squamous cell carcinoma.
    Yoon TM; Kim SA; Lee DH; Lee JK; Park YL; Lee KH; Chung IJ; Joo YE; Lim SC
    Oncol Rep; 2017 Jun; 37(6):3667-3673. PubMed ID: 28440463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The FA/BRCA Pathway Identified as the Major Predictor of Cisplatin Response in Head and Neck Cancer by Functional Genomics.
    Martens-de Kemp SR; Brink A; van der Meulen IH; de Menezes RX; Te Beest DE; Leemans CR; van Beusechem VW; Braakhuis BJ; Brakenhoff RH
    Mol Cancer Ther; 2017 Mar; 16(3):540-550. PubMed ID: 27980104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of survivin, X-linked inhibitor of apoptosis protein and second mitochondria-derived activator of caspases expression in advanced non-small-cell lung cancer patients.
    Chen P; Li J; Ge LP; Dai CH; Li XQ
    Respirology; 2010 Apr; 15(3):501-9. PubMed ID: 20210890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
    Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
    Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
    [No Abstract]   [Full Text] [Related]  

  • 18. Induction of apoptosis and sensitization of head and neck squamous carcinoma cells to cisplatin by targeting survivin gene expression.
    Khan Z; Tiwari RP; Khan N; Prasad GB; Bisen PS
    Curr Gene Ther; 2012 Dec; 12(6):444-53. PubMed ID: 22974420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Butyrate response factor 1 enhances cisplatin sensitivity in human head and neck squamous cell carcinoma cell lines.
    Lee SK; Kim SB; Kim JS; Moon CH; Han MS; Lee BJ; Chung DK; Min YJ; Park JH; Choi DH; Cho HR; Park SK; Park JW
    Int J Cancer; 2005 Oct; 117(1):32-40. PubMed ID: 15880358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCND1 as a predictive biomarker of neoadjuvant chemotherapy in patients with locally advanced head and neck squamous cell carcinoma.
    Feng Z; Guo W; Zhang C; Xu Q; Zhang P; Sun J; Zhu H; Wang Z; Li J; Wang L; Wang B; Ren G; Ji T; Tu W; Yang X; Qiu W; Mao L; Zhang Z; Chen W
    PLoS One; 2011; 6(10):e26399. PubMed ID: 22065993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.